addition of two different drugs Buprenorphine or Dexamethasone to Levobupivacaine in TAP block may or may not provide better pain control in inguinal hernia repair
- Conditions
- ASA grade 1 and 2
- Registration Number
- CTRI/2017/10/010081
- Lead Sponsor
- Dr S N medical collage and attached hospital Jodhpur
- Brief Summary
This is a prospective randomized double blind study. The institutional ethical committee clearance obtained and informed consent would be taken from patient. The total 93 patients of age between 18-60 years, ASA Grade 1 and 2 undergoing unilateral inguinal hernioplasty would be randomly divided in three groups of 31 each. After surgery under spinal anaesthesia group L will receive 20ml 0.25% levobupivacaine + 1 ml NS, group LB will receive 20ml 0.25% levobupivacaine + 0.3mg buprenorphine and group LD will receive 20ml 0.25% levobupivacaine + 4mg dexamethasone, total 21ml in each ultrasound guided TAP block. Postoperatively we will record and compare the duration of analgesia, total rescue analgesic (tramadol) consumption and NRS pain score in first 24 hrs.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 93
- Age group of 18 –60 years of both sex 2.
- ASA grade I and II 3.
- Weight 50-100 kg 4.
- Patients undergoing surgery for unilateral inguinal hernia repair.
- Patient’s or relative’s refusal 2.
- Known hypersensitivity to local anesthetics 3.
- Opioid addicts 4.
- Any chronic systemic illness 5.
- Bleeding diasthesis 6.
- Anatomical abnormality 7.
- Any infection at the regional site 8.
- Pregnant women 9.
- Pre existing peripheral neuropathy or neurological deficits.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare post operative pain score (NRS). 24 hours Duration of analgesia. 24 hours To compare post operative rescue analgesic (inj.tramadol) requirment. 24 hours
- Secondary Outcome Measures
Name Time Method •To compare the hemodynamic and respiratory parameters. 24 hours •Patient’s satisfaction. 24 hours •Any side effects or complications of study drugs and block. 24 hours
Trial Locations
- Locations (1)
MDM hospital
🇮🇳Jodhpur, RAJASTHAN, India
MDM hospital🇮🇳Jodhpur, RAJASTHAN, IndiaDr Satya narayan seerviPrincipal investigator7737658824drsatyanarayanseervi@gmail.com